Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
Elhadd T, Bashir M, Baager KA, Ali HA, Almohannadi DHS, Dabbous Z, Malik RA, Abou-Samra AB; PROFAST Ramadan Study Group. Elhadd T, et al. Diabetes Res Clin Pract. 2021 Feb;172:108589. doi: 10.1016/j.diabres.2020.108589. Epub 2020 Dec 13. Diabetes Res Clin Pract. 2021. PMID: 33316309
Incidence of hypoglycaemia in patients with type-2 diabetes taking multiple glucose lowering therapies during Ramadan: the PROFAST Ramadan Study.
Elhadd T, Dabbous Z, Bashir M, Elzouki A, Ghadban W, Baagar K, Benjamin S, Hassanien M, Saeed AAM, Dukhan K, Malik RA, Abou-Samra AB; PROFAST Study Group. Elhadd T, et al. J Diabetes Metab Disord. 2018 Nov 19;17(2):309-314. doi: 10.1007/s40200-018-0374-2. eCollection 2018 Dec. J Diabetes Metab Disord. 2018. PMID: 30918866 Free PMC article.
Artificial Intelligence (AI) based machine learning models predict glucose variability and hypoglycaemia risk in patients with type 2 diabetes on a multiple drug regimen who fast during ramadan (The PROFAST - IT Ramadan study).
Elhadd T, Mall R, Bashir M, Palotti J, Fernandez-Luque L, Farooq F, Mohanadi DA, Dabbous Z, Malik RA, Abou-Samra AB; for PROFAST-Ramadan Study Group. Elhadd T, et al. Diabetes Res Clin Pract. 2020 Nov;169:108388. doi: 10.1016/j.diabres.2020.108388. Epub 2020 Aug 26. Diabetes Res Clin Pract. 2020. PMID: 32858096 Free article.
Differential effects of gender and patient background diversity on the changes in metabolic and biophysical profiles in people with type-2 diabetes from different ethnicities who fast during Ramadan (H1439); a prospective study from Qatar.
Dabbous Z, Bashir M, Elzouki AN, Ahmed MS, Farouk S, Hassanien M, Malik RA, Abou Samra AB, Elhadd T; PROFAST Study Group. Dabbous Z, et al. Among authors: elhadd t. Diabetes Res Clin Pract. 2019 Jun;152:171-176. doi: 10.1016/j.diabres.2019.03.032. Epub 2019 Mar 28. Diabetes Res Clin Pract. 2019. PMID: 30930290
Diabetes and Ramadan: Practical guidelines 2021.
Hassanein M, Afandi B, Yakoob Ahmedani M, Mohammad Alamoudi R, Alawadi F, Bajaj HS, Basit A, Bennakhi A, El Sayed AA, Hamdy O, Hanif W, Jabbar A, Kleinebreil L, Lessan N, Shaltout I, Mohamad Wan Bebakar W, Abdelgadir E, Abdo S, Al Ozairi E, Al Saleh Y, Alarouj M, Ali T, Ali Almadani A, Helmy Assaad-Khalil S, Bashier AMK, Arifi Beshyah S, Buyukbese MA, Ahmad Chowdhury T, Norou Diop S, Samir Elbarbary N, Elhadd TA, Eliana F, Ezzat Faris M, Hafidh K, Hussein Z, Iraqi H, Kaplan W, Khan TS, Khunti K, Maher S, Malek R, Malik RA, Mohamed M, Sayed Kamel Mohamed M, Ahmed Mohamed N, Pathan S, Rashid F, Sahay RK, Taha Salih B, Sandid MA, Shaikh S, Slim I, Tayeb K, Mohd Yusof BN, Binte Zainudin S. Hassanein M, et al. Among authors: elhadd ta. Diabetes Res Clin Pract. 2022 Mar;185:109185. doi: 10.1016/j.diabres.2021.109185. Epub 2022 Jan 8. Diabetes Res Clin Pract. 2022. PMID: 35016991 Review.
Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study.
Malik RA, Elhadd T, Alattar A, Al Shaikh A, Al Randi M, Arora R, Al-Sifri S, Akil Y, Magdy A, Naqvi M, Hassanein M. Malik RA, et al. Among authors: elhadd t. Diabetes Ther. 2022 Mar;13(3):569-581. doi: 10.1007/s13300-022-01225-z. Epub 2022 Mar 3. Diabetes Ther. 2022. PMID: 35239165 Free PMC article.
Prevalence and risk factors for painful diabetic neuropathy in secondary healthcare in Qatar.
Ponirakis G, Elhadd T, Chinnaiyan S, Dabbous Z, Siddiqui M, Al-Muhannadi H, Petropoulos I, Khan A, Ashawesh KA, Dukhan KM, Mahfoud ZR, Murgatroyd C, Slevin M, Malik RA. Ponirakis G, et al. Among authors: elhadd t. J Diabetes Investig. 2019 Nov;10(6):1558-1564. doi: 10.1111/jdi.13037. Epub 2019 Apr 2. J Diabetes Investig. 2019. PMID: 30860314 Free PMC article.
Prevalence and management of diabetic neuropathy in secondary care in Qatar.
Ponirakis G, Elhadd T, Chinnaiyan S, Dabbous Z, Siddiqui M, Al-Muhannadi H, Petropoulos IN, Khan A, Ashawesh KAE, Dukhan KMO, Mahfoud ZR, Murgatroyd C, Slevin M, Malik RA. Ponirakis G, et al. Among authors: elhadd t. Diabetes Metab Res Rev. 2020 May;36(4):e3286. doi: 10.1002/dmrr.3286. Epub 2020 Jan 23. Diabetes Metab Res Rev. 2020. PMID: 31913560
58 results